Catalyst Pharmaceuticals
CPRX
#3621
Rank
โ‚น368.78 B
Marketcap
โ‚น3,013
Share price
-0.03%
Change (1 day)
43.31%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: โ‚น368.78 Billion

As of May 2026 Catalyst Pharmaceuticals has a market cap of โ‚น368.78 Billion. This makes Catalyst Pharmaceuticals the world's 3621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น368.78 B37.26%
2025โ‚น268.67 B22.3%
2024โ‚น219.68 B47.25%
2023โ‚น149.19 B-6.86%
2022โ‚น160.18 B208.65%
2021โ‚น51.89 B104.72%
2020โ‚น25.35 B-8.32%
2019โ‚น27.65 B100.47%
2018โ‚น13.79 B-46.09%
2017โ‚น25.58 B332.52%
2016โ‚น5.91 B-56.15%
2015โ‚น13.48 B3.68%
2014โ‚น13.01 B99.5%
2013โ‚น6.52 B561.04%
2012โ‚น0.98 B-41.47%
2011โ‚น1.68 B95.92%
2010โ‚น0.86 B63.17%
2009โ‚น0.52 B-56.65%
2008โ‚น1.21 B-28.28%
2007โ‚น1.69 B-36.65%
2006โ‚น2.67 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

โ‚น368.90 Billion
by Nasdaq info icon info icon
โ‚น368.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.491 T 14,404.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.217 T 3,755.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น14.966 T 3,958.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น171.91 B-53.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น79.24 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น948.57 B 157.22%๐Ÿ‡บ๐Ÿ‡ธ USA